Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with ‘aggressive’ multiple sclerosis

BACKGROUND: Autologous haematopoietic stem cell transplantation (AHSCT) is an effective treatment for patients with multiple sclerosis (MS) who have highly active disease, despite the use of standard disease-modifying therapies (DMTs). However, the optimal time for offering AHSCT to patients with ‘a...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Mult Scler
Main Authors: Das, J, Snowden, JA, Burman, J, Freedman, MS, Atkins, H, Bowman, M, Burt, RK, Saccardi, R, Innocenti, C, Mistry, S, Laud, PJ, Jessop, H, Sharrack, B
Formato: Artigo
Idioma:Inglês
Publicado: SAGE Publications 2021
Assuntos:
Original Research Papers
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8226372/
https://ncbi.nlm.nih.gov/pubmed/33565902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458520985238
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares